OVOCA BIO PLC (OVXA.I) Stock Income Statement
DUB:OVXA - Euronext Dublin - IE00B4XVDC01 - Common Stock - Currency: EUR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | N/A | N/A | 0.00 | 36.00K | 409.00K | |||
| Operating Expenses | 849.00K | 3.97M | 5.86M | 2.21M | 2.31M | |||
| Research and Development | 419.00K | 2.46M | 3.55M | 688.00K | 619.00K | |||
| Selling, General, and Administrative Expenses | 1.15M | 2.44M | 2.46M | 1.45M | 1.62M | |||
| Operating Income | -849.00K | -3.97M | -5.86M | -2.21M | -2.31M | |||
| Interest Income/Expense | 41.00K | -1.33M | 613.00K | -117.00K | 413.00K | |||
| Other Income/Expense | N/A | N/A | -613.00K | 109.00K | N/A | |||
| Non Recurring Items | -4.30M | -313.00K | 0.00 | 4.00K | 0.00 | |||
| Income Before Taxes | -5.10M | -5.61M | -5.25M | -2.32M | -1.90M | |||
| Income Tax | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Net Income | -4.70M | -5.61M | -5.47M | -2.34M | -1.57M | |||
| EBITDA | -549.00K | -3.44M | -5.78M | -2.13M | -2.24M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.06 | -0.07 | -0.06 | -0.03 | -0.02 | |||
| Statistics | ||||||||
All data in EUR